Medicines Co. (MDCO) Tops Q1 EPS by 5c

April 27, 2011 8:09 AM EDT
Medicines Co. (Nasdaq: MDCO) reported Q1 EPS of $0.45, $0.05 better than the analyst estimate of $0.40. Revenue for the quarter came in at $112.1 million versus the consensus estimate of $109.69 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings